Plasma amino acid analysis in dogs with experimentally induced hepatocellular and obstructive jaundice.
Plasma amino acid concentrations were determined weekly for 4 weeks in 6 sham-operated control dogs, in 6 sham-operated dogs after induction of liver disease with dimethylnitrosamine (DMNA), and in 6 dogs after surgical ligation of the common bile duct. Results were compared with standard biochemical indices of liver function and with histologic changes in serial liver biopsy specimens. Concentrations of most amino acids increased after 2 weeks in DMNA-treated dogs, whereas they were normal or decreased in bile duct-ligated dogs. With increasing severity of the liver disease, the molar ratio (normal mean +/- SEM = 3.48 +/- 0.14) in DMNA-treated dogs decreased to 2.42 +/- 0.19 by 2 weeks and to 1.17 +/- 0.09 by 4 weeks. The ratio remained normal in bile duct-ligated dogs. Molar ratio and aromatic amino acid concentrations correlated better with hepatic necrosis and inflammation than did standard biochemical indices (eg, bilirubin, liver enzymes). Therefore, plasma amino acid analysis and determination of the molar ratio may be useful in the differential diagnosis of hepatocellular and obstructive jaundice in dogs. A decrease in the molar ratio may reflect portal hypertension and hepatocellular disease.
D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D000596:Amino Acids / Q000097:blood*; D000818:Animals; D001663:Bilirubin / Q000097:blood; D001651:Cholestasis, Extrahepatic / Q000175:diagnosis / Q000662:veterinary*; D002780:Cholestasis, Intrahepatic / Q000175:diagnosis / Q000662:veterinary*; D002784:Cholesterol / Q000097:blood; D003937:Diagnosis, Differential; D004128:Dimethylnitrosamine; D004283:Dog Diseases / Q000175:diagnosis*; D004285:Dogs; D006500:Hepatic Duct, Common / Q000601:surgery; D008026:Ligation; D008099:Liver / Q000473:pathology
D000596:Amino Acids; D002784:Cholesterol; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D004128:Dimethylnitrosamine; D001663:Bilirubin